Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency.
نویسندگان
چکیده
for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.1 This method depends upon the fluorescence of reduced triphosphopyridine nucleotide (TPNH ) as an indicator of G-6-PD activity. Ten j.d. of whole blood are added to 100 jil. of a screening solution containing glucose-6-phosphate, TPN, buffer, and saponin. A spot is made on ordinary filter paper after 5 minutes incubation at room temperature. The spot is permitted to dry, and is then examined for fluorescence under long-wave UV light. We now introduce modifications of the procedure which may enhance its usefulness under certain circumstances. It has been found that when the test reagent originally described is used the fluorescence on filter paper fades relatively rapidly. It is difficult to differentiate normal from enzyme-deficient samples after more than 24 hours. While this does not pose any problem for the ordinary clinical laboratory, it may limit the usefulness of the technic for field surveys. In such studies it may be desirable to examine the results of tests under ultraviolet light in a distant central laboratory, possibly after several days’ delay. It has been found that the stability, and indeed the initial intensity, of fluorescence can be greatly enhanced by substituting an appropriate trishydrochloride buffer for phosphate buffer. A second modification makes it possible to eliminate almost entirely the slight fluorescence which sometimes appears when blood from individuals with the mildest forms of glucose-6-phosphate dehydrogenase deficiency are examined, especially using a reaction mixture buffered with tris. This fluorescence can be eliminated by adding oxidized glutathione (GSSG) to the reaction mixture. When GSSG is present, TPNH is oxidized through the action of glutathione reductase (GSSG-R). But the activity of glutathione reductase is normally only approximately one-quarter of that of the activity of the glucose-6-phosphate dehydrogenase-phosphogluconic dehydrogenase sys-
منابع مشابه
Prevalence of Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency in Jiroft City in Southern Iran
Background and Aims: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a global problem and the most common cause of jaundice in neonates. Hence, this study was conducted to investigate the prevalence of G6PD deficiency in Jiroft city in southern Kerman. Materials and Methods: This descriptive cross-sectional study was carried out from 2016 to 2019. Blood samples were taken from all patie...
متن کاملPrevalence of Glucose-6-Phosphate Dehydrogenase Deficiency among Male Donors in Shiraz, Southern Iran
The overall incidence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Iranian population is estimated around 10%-14.9%. G6PD deficiency is an X-linked disorder and 80% of donors are usually male. At present, donors’ blood is not routinely screened for G6PD deficiency in Iran blood bank where for detecting such enzyme deficiency, reliance is placed on pre-donation data. Thus, the G6PD ...
متن کاملPrevalence of G6PD deficiency in neonates referred to Semnan University of Medical Science´s screening Lab
Abstract Background and objectives: Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme in the pentose phosphate pathway. G6PD deficiency (an X-linked recessive hereditary disease) is an inherited condition affecting approximately 3% of the people globally. This deficiency can cause hemolytic anemia and jaundice in neonates. The goal of this study is to detect the prevalence of G6PD deficienc...
متن کاملPossible Association between Glucose-6-Phosphate Dehydrogenase Deficiency and the Development of Preeclampsia
Glucose-6-Phosphate dehydrogenase (G6PD) deficiency is a common enzyme deficiency in the world. It's Prevalence inIranis about 12% in male & about 1% in female. The present study did examine the relation between the development of preeclampsia and G6PD deficiency. It was investigated whether or not the risk of preeclampsia in G6PD deficient women is higher than that in normal pregnant women.A t...
متن کاملNeonatal Screening for G6PD Deficiency in Mazandaran Province, Iran 2007-2010
Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common disease of the hexose monophosphate pathway existing in more than 400 million people worldwide. The aim of this study was to identify neonates with G6PD deficiency following national program for screening and education of affected newborns’ parents started since June 2007 in Mazandaran, a northern Province of Ira...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Blood
دوره 32 5 شماره
صفحات -
تاریخ انتشار 1968